Headache

Article	Citations
Anxiety, depression, and headache‐related disability in a large pediatric clinic–based sample	135
Genetic migraine disorders and the response to calcitonin gene‐related peptide antagonist treatment	98
Facial variant of epicrania fugax secondary to a cerebellopontine angle meningioma	83
Pilot study evaluating treatment with sumatriptan for moderate to severe post‐traumatic headache: A phase 2 open‐label study	58
A retrospective analysis of the use of candesartan for migraine prevention in adolescents	56
Migraine and peripheral pain models show differential alterations in neuronal complexity	45
Erratum	45
Assessing the influence of migraine on ischemic penumbra and on the prognosis of ischemic stroke: A prospective cohort study	40
Evidence for increased background neural noise in migraine with aura: Hyperactive but not hyperresponsive	38
Identifying cognitive‐affective mechanisms underlying disability in episodic migraine: Using the fear avoidance model to examine interactions	38
Virtual issue: Education in headache medicine: Insights and advancements from 2023 to 2024	35
Effect of caffeine and caffeine cessation on cerebrovascular reactivity in patients with migraine	33
Migraine screening in English and Spanish	31
Migraine treatment in pregnancy: A survey of comfort and treatment practices of women's healthcare providers	31
Persistence, effectiveness, and tolerability of anti‐calcitonin gene–related peptide monoclonal antibodies in patients with chronic migraine	31
Drug‐resistant epicrania fugax: Responding to onabotulinumtoxinA	30
Normal glymphatic system function in patients with new daily persistent headache using diffusion tensor image analysis along the perivascular space	30
Characteristics associated with response to subcutaneously administered anti‐CGRP monoclonal antibody medications in a real‐world community cohort of persons living with migraine: A retrospective clin	30
A 52‐week open‐label extension study to evaluate the safety and efficacy of oral rimegepant for the preventive treatment of migraine	30
Popping the balloon: Abrupt onset of a spinal CSF leak and spontaneous intracranial hypotension in idiopathic intracranial hypertension, a case report	29
The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine	29
Neuromodulation for primary headache disorders: Advantages and challenges	27
Sequential administration of peripheral nerve blocks and  onabotulinumtoxinA for the treatment of chronic migraine and other headache disorders—A ret	26
Effects of fremanezumab on migraine‐associated symptoms and medication use in Japanese and Korean patients with episodic migraine: Exploratory endpoint analysis of a multicenter, randomized, double‐bl	26
Index	26

A retrospective review of sex differences of white matter hyperintensities in brain MRI of patients with migraine	26
Developing and delivering a migraine disparities and diagnosis undergraduate medical educational program to underrepresented in medicine medical student members of the Student National Medical Associa	26
Skin wetness sensitivity across body sites commonly affected by pain in people with migraine	25
Sex and gender: Opportunities to expand research and understanding within headache medicine	25
Effect of erenumab versus other migraine preventive medications on cardiovascular and cerebrovascular outcomes: A United States claims database‐based observational cohort study	24
Patient preference for early onset of efficacy of preventive migraine treatments	24
Patient headache questionnaires can improve headache diagnosis and treatment in children	23
Long‐term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysis	23
Headache and psychological variables as predictors of disability in individuals with primary headache disorders	23
Crystal‐clear days and unclear days in migraine: A population‐based study	23
Patients with chronic post‐dural puncture headache do not have typical imaging features of intracranial hypotension: An MRI study using the Bern scor	23
Dietary sodium and headache are linked by cerebrospinal fluid sodium concentration to sodium‐specific appetite, tolerance, and perceptive reward	23
The teaching of headache medicine in France: A questionnaire‐based study	23
CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity	22
Prevalence of primary stabbing headache: A meta‐analysis	22
TRPM3 activation causes CGRP release in trigeminal neurons: Implications for migraine mechanisms	22
Routine migraine screening as a standard of care for Women's health: A position statement from the American Headache Society	22
Patient‐reported experiences with migraine‐related cognitive symptoms: Results of the MiCOAS qualitative study	22
Remote electrical neuromodulation to treat children and adolescents with migraine in the emergency department: A randomized double‐dummy pilot trial	21
Treatment effectiveness of galcanezumab versus traditional oral migraine preventive medications at 3 months: Results from the TRIUMPH study	21
The 2024 Headache editorial board Conflict of Interest Declarations	21
Challenges and opportunities for estimating and assessing migraine prevalence, incidence and impact across study populations and methodologies: Bridging global and United Stat	20
Assessing blood pressure changes and hypertension‐related outcomes in patients with migraine treated with erenumab: A systematic review and meta‐analysis	19
Issue Information	19
Protracted headache after COVID‐19: A case series of 31 patients from a tertiary headache center	18
Validation of a Portuguese version of the four‐item Migraine Interictal Burden Scale	18
Dystonia phenomenology and treatment response in migraine	18
The elephant in the room: How the underfunding of headache research stunts the field	18
	18
Prevalence, characteristics, and factors associated with caffeine‐withdrawal headache during the first day of Ramadan	18
Recurrent painful ophthalmoplegic neuropathy with headache and oculomotor palsy 18 years apart	18
OnabotulinumtoxinA as a promising treatment for primary trochlear headache: A retrospective case series	18
Headache and acute cerebrovascular disease: How do we differentiate primary and secondary headache disorders in the emergency setting?	18
Engagement and predictors of use of a smartphone app for migraine self‐management: A secondary analysis of the EMMA trial	17
Intravenous magnesium and methocarbamol for acute pain crises in refractory trigeminal neuralgia: A retrospective analysis	17
A large language model–based generative natural language processing framework fine‐tuned on clinical notes accurately extracts headache frequency from electronic health records	17
Changes in cognitive appraisal in a randomized controlled trial of mindfulness‐based cognitive therapy for patients with migraine	16
Socioeconomic and geographic inequalities in headache disability in Brazil: The 2019 National Health Survey	16
Burden of migraine in Brazil: A cross‐sectional real‐world study	16
Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trials	16
Emergency department utilization among patients who receive outpatient specialty care for headache: A retrospective cohort study analysis	16
Evaluation of vascular risk in patients with migraine with and without aura treated with erenumab: Post hoc analysis of pooled long‐term clinical trial data	16
Alcohol as a trigger of migraine attacks in people with migraine. Results from a large prospective cohort study in English‐speaking countries	16
Post‐vaccination headache reporting: Trends according to the Vaccine Adverse Events Reporting System	16
The 2025 Headache Editorial Board conflict of interest declarations	16
	15
Red flags in headache care	15
Plain Language Summary Publication: Investigating the causal and genetic relationship between migraine and Parkinson’s disease	15
Prediction of individual trigeminal pain sensitivity from gray matter structure within the sensorimotor network	15
Headache in individuals undergoing hormone therapy for gender transition: A cross‐sectional, observational study	15

Essential components of care in a multidisciplinary headache center: Perspectives from headache neurology specialists	15
Issue Information	15
Different dosage regimens of erenumab for the treatment of migraine: A systematic review and meta‐analysis of the efficacy and safety of randomized controlled trials	15
Afterimage duration differs for migraine with or without aura	15
Development and pharmacological characterization of novel multi‐ calcitonin gene‐related peptide and pituitary adenylate cyclase‐activating peptide receptor antagonists	15
Clinical factors associated with day‐to‐day peak pain severity in individuals with chronic migraine: A cohort study using daily prospective diary data	14
Issue Information	14
Challenges in the management of new daily persistent headache at a tertiary headache center—A retrospective real‐world evidence study	14
Remote electrical neuromodulation for reducing procedural pain in patients with chronic migraine receiving onabotulinumtoxinA injections: A randomize	14
Effect of galcanezumab in women with episodic migraine meeting criteria for menstrually related migraine: A post hoc analysis of EVOLVE ‐1 and	14
Melatonin for migraine prevention in children and adolescents: A randomized, double‐blind, placebo‐controlled trial after single‐blind placebo lead‐in	14
Decision‐making impairment under ambiguity but not under risk may underlie medication overuse in patients with chronic migraine	14
Basic Science Prize Award 2024	14
Eicosapentaenoic acid versus placebo as adjunctive therapy in chronic migraine: A randomized controlled trial	14
The cortical spreading depression/migraine aura hypothesis – Finally some definitive evidence	14
Intracranial hypotension as a contributor to isolated cortical vein thrombosis	13
Effect of wildfire smoke on primary headache disorders remains unclear	13
Plasma calcitonin gene–related peptide and nerve growth factor as headache and pain biomarkers in recently deployed soldiers with and without a recent concussion	13
Arachnoid granulations in idiopathic intracranial hypertension: Do they have an influence?	13
Plain Language Summary Publication: The 2023 protocol for update to acute treatment of adults with migraine in the emergency department: The American headache society evidence assessment of parenteral	13
Characterization of trigeminal C‐fiber reactivity through capsaicin‐induced release of calcitonin gene‐related peptide	13
Essential but often overlooked reporting elements for Headache manuscripts	13
Letters from nobody: The problem of AI ‐written Letters to the Editor	13
Beyond aura: Understanding migraine as a cycling pan‐sensory threshold disease	13
American Headache Society 64th Annual Scientific Meeting June 9–12, 2022 Denver, Colorado	13
Factors associated with efficacy of occipital nerve stimulation in medically intractable chronic cluster headache	12
Are psychological interventions efficacious for adults with migraine? A systematic review and meta‐analysis	12
Issue Information	12
Digital headache self‐management interventions for patients with a primary headache disorder: A systematic review of randomized controlled trials	12
Comparison and predictors of chronic migraine vs. new daily persistent headache presenting with a chronic migraine phenotype	12
Headache in transgender men using gender‐affirming hormone therapy: A case–control study	12
Treatment of abdominal migraine in an 8‐year‐old child with calcitonin gene‐related peptide receptor antagonist: A case report	12
Efficacy and safety of rimegepant for the acute treatment of migraine in Japan: A dose‐ranging, double‐blind, randomized controlled trial	12
Long‐term effectiveness of eptinezumab in the treatment of patients with chronic migraine and medication‐overuse headache	12
Correction to “Smartphone‐delivered progressive muscle relaxation for the treatment of migraine in primary care: A randomized controlled trial”	11
Clinical characteristics and patient‐reported outcomes of chronic and episodic migraine patients at a US tertiary headache center: A retrospective observational study	11
Reducing the physical, social, and emotional impact of episodic migraine: Results from erenumab STRIVE and ARISE phase III randomized trials	11
Insomnia severity in migraine: The role of headache frequency, aura status, and comorbidities—A cross‐sectional study	11
Response to: Disagreement with Categorization of Clinical Trials included in Treadwell et al. Systematic Review and Meta‐Analysis	11
Zavegepant nasal spray for the acute treatment of migraine: A Phase 2/3 double‐blind, randomized, placebo‐controlled, dose‐ranging trial	11
A randomized trial of ketorolac and metoclopramide for migraine in the emergency department	11
Causal associations between genetically predicted placental weight and migraine	11
Secondary nummular headache: Are they more common than we thought?	11
Validity of self‐reported migraine in adolescents and children	10
The impact of updates in headache quality measures on adherence to best practices in a neurology resident clinic: A quality improvement study	10
The link between reversible cerebral vasoconstriction syndrome and transient global amnesia	10
Visual hypersensitivity in patients treated with anti‐calcitonin gene–related peptide (receptor) monoclonal antibodies	10
	10
Post hoc analysis of clinical trial data and pharmacokinetic data to assess wearing‐off of erenumab within monthly treatment cycle	10
Issue Information	10
Migraine epidemiology in collegiate student‐athletes: Findings from the Concussion Assessment, Research, and Education (CARE) Consortium	10
Issue Information	10
Plain Language Summary Publication: Evaluating the use of paracetamol to prevent fasting headache during the first week of Ramadan: A randomized, open‐label, clinical trial	10
Exploring the impact of acute SARS‐CoV‐2 infection on headache pattern in patients with migraine: A novel Bayesian analysis	10
Blink reflex: A practical test to evaluate the trigeminal nerve injury following percutaneous balloon compression for the treatment of trigeminal neuralgia	10
Glial activation in pain and emotional processing regions in the nitroglycerin mouse model of chronic migraine	9
Migraine in the context of chronic primary pain, chronic overlapping pain disorders, and functional somatic disorders: A narrative review	9
Cluster Analysis of Migraine‐associated Symptoms (CAMS) in youth: A retrospective cross‐sectional multicenter study	9
Real‐world barriers to health care utilization among people living with migraine: Insights from the All of Us Research Program	9
The pathogenic role of calcitonin gene‐related peptide and predictors of new‐onset migraine and long‐term outcomes after transcatheter atrial septal defect closure	9
Headache diagnosis and treatment: A pilot knowledge and needs assessment among physical therapists	9
Patient headache questionnaires can improve headache diagnosis and treatment in children	9
Celebrating Headache 's 2023 graduating class of Assistant Editors	9
Migraine and infertility, merging concepts in women's reproductive health: A narrative review	9
Magnetoencephalography studies in migraine and headache disorders: A systematic review	9
Improving distress perception and mutuality in migraine caregivers after 6 months of galcanezumab treatment	9
2025 guideline update to acute treatment of migraine for adults in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies	9
Issue Information	9
The Chronic Headache Self‐Efficacy Scale: Development and assessment of measurement properties	9
Identifying and predicting headache trajectories among those with acute post‐traumatic headache	9
Counting the cost: How migraine shapes lives and economies	9
Beyond movement: Headache in patients with functional movement disorders	9
Mechanisms of change in posttraumatic headache–related disability: A mediation model	9
Time to reconsider the association between migraine and white matter hyperintensities?	9
Letter to the Editor regarding “Impact of perilesional edema on severity of migraine in patients with calcified neurocysticercosis: A prospective evaluation”	9
Effectiveness and tolerability of galcanezumab for migraine prevention in patients ≥65 years: A real‐life multicenter study	9
	9
Symptomatic visual snow in acute ischemic stroke: A case series	9
The effectiveness of parenteral agents for pain reduction in patients with migraine presenting to emergency settings: A systematic review and network analysis	9
Virtual issue: Recent advances in pediatric headache: Bridging the data gap	8

Issue Information	8
Circadian functional changes of pain‐processing brainstem nuclei and implications for cluster headache: A 7 Tesla imaging study	8
A post hoc analysis of migraine‐associated symptoms from the phase 3 randomized, double‐blind, sham‐controlled Trial of External trigeminal nerve stimulation for the Acute treatment of Migraine (	8
Evaluating associations of migraine‐related vertigo	8
Efficacy of an educational website on headaches in schoolchildren: A cluster‐randomized controlled trial	8
Neuropathic changes in corneal nerve endings—A potential objective biomarker for migraine frequency and response to treatment	8
Trainee highlights	8
A critical appraisal of the International Classification of Headache Disorders migraine diagnostic criteria based on a retrospective multicenter cross‐sectional headache registry study in youth	8
	8
The importance of patient and family perspectives of clinical decisions in pediatric headache	8
Cerebrovascular reactivity to hypercapnia in patients with migraine: A dual‐echo arterial spin labeling MRI study	8
Heightened migraine risk in patients with rheumatoid arthritis: A national retrospective cohort study	8
Machine learning models and classification algorithms in the diagnosis of vestibular migraine: A systematic review and meta‐analysis	8
American Headache Society 67th Annual Scientific Meeting June 19–22, 2025 Minneapolis, Minnesota	8
A unifying disease model of idiopathic intracranial hypertension: A narrative review	8
Long‐term evolution of white and gray matter structural properties in migraine	8
Migraine, idiopathic intracranial hypertension, and calcitonin gene‐related peptide antibodies	8
Heavy metal and trace element alterations in patients during a migraine attack	8
Exploratory investigation of a patient‐informed low‐dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double‐blind, placebo‐controlled trial	8
The impact of fear of attacks on pain‐related disability in cluster headache: Insights from the fear avoidance model	8
	8
Sex‐specific differences in the relationship between AHA Life's Essential 8 factors and migraine disorders: A cross‐sectional evaluation in	7
Ramadan fasting in smokers with primary headache disorders: Impact of nicotine dependence on headache frequency and severity	7
Learning headache triggers through experience: A laboratory study	7
Trainee highlights	7
Plain Language Summary Publication: Regulation of headache response and transcriptomic network by the trigeminal ganglion clock	7
Baseline factors associated with post‐stenting intracranial pressure in patients with idiopathic intracranial hypertension with venous sinus stenosis	7
Healthcare costs and resource utilization in patients with migraine treated with erenumab: A retrospective, non‐interventional study using claims data from the United States	7
	7
Headache basic science prize	7
Indomethacin‐responsive idiopathic red ear syndrome: A pediatric case	7
Twenty twenty … two: Headache and COVID‐19	7
Investigating the effects of weather on headache occurrence using a smartphone application and artificial intelligence: A retrospective observational cross‐sectional study	7
Good News? Bad News? Idiopathic intracranial hypertension and migraine	7
Sustained response of galcanezumab in migraine prevention: Patient‐level data from a post hoc analysis in patients with episodic or chronic migraine	7
Potential drug interaction between calcitonin gene‐related peptide antagonists and neonatal Fc receptor inhibitors	7
The 15‐day threshold in the definition of chronic migraine is reasonable and sufficient—Five reasons for not changing the ICHD‐3 definition	7
Insight of a headache medicine provider in Indian Health Service: A personal and professional observation	7
Comparative prevalence and characteristics of fabricated citations in large language models in headache medicine	7
Preliminary exploration of a multidimensional sleep health composite in adolescent females with frequent migraine	7
Intranasal treatment of cluster headache: A response	7
A placebo controlled, randomized clinical trial of galcanezumab for vestibular migraine: The INVESTMENT study	7
Issue Information	7
Phenotype of midfacial pain in 12 new cases—A multidisciplinary idiopathic facial pain syndrome	7
Headache launches the publication of plain language summaries	7
Multi‐region local field potential signatures and brain coherence alternations in response to nitroglycerin‐induced migraine attacks	7
Lacosamide for refractory trigeminal neuralgia and other facial pain—Case report	7
Different characteristics of cortical spreading depression in the sleep and wake states	7
	7
Welcoming Headache 's 2024 incoming class of Assistant Editors	7
Correction to “A causative role for remote dural puncture and resultant arachnoid bleb in new daily persistent headache: A case report”	7
Diagnostic accuracy of an artificial intelligence online engine in migraine: A multi‐center study	7
Asking the right questions: The value of headache specialty care	7
Challenges and complexities in designing cluster headache prevention clinical trials: A narrative review	6
Pain medication beliefs in individuals with headache	6
Management and outcomes of persistent headache after accidental dural puncture in the obstetric population: A 9‐year prospective audit	6
	6
Spontaneous involution of a large pineal cyst: Case report and narrative review	6
Patterns of clinical and imaging presentations in patients with spontaneous intracranial hypotension due to spinal cerebrospinal fluid venous fistula: A single‐center retrospective cross‐sectional stu	6
Development and initial validation of the Kiswahili version of the Migraine Disability Assessment (MIDAS‐K) questionnaire	6
The complex relationship between alcohol and migraine	6
A multicenter, randomized, double‐blind, placebo‐controlled, crossover trial to evaluate the efficacy and safety of zolmitriptan nasal spray for the acute treatment of migraine in patients aged 6 to 1	6
New insight into the neural mechanisms of migraine in adolescents: Relationships with sleep	6
Headache neuroimaging: A survey of current practice, barriers, and facilitators to optimal use	6
Challenges and complexities in designing cluster headache prevention clinical trials: A narrative review	6
Persistence of headache and its relation to other major sequelae following traumatic brain injury at 2–8 years after deployment‐related traumatic brain injury in veterans of Afghanistan and Iraq wars	6
Long‐term reductions in acute headache medication use after eptinezumab treatment in patients with migraine and prior preventive treatment failures: Post hoc analysis of the D	6
Author response to comments on our article “Impact of perilesional edema on severity of migraine in patients with calcified neurocysticercosis: A prospective evaluation”	6
Efficacy of galcanezumab in proline‐rich transmembrane protein 2 ( PRRT2 )	6
Effects of multiple‐dose administration of zavegepant nasal spray on the single‐dose pharmacokinetics of ethinyl estradiol‐levonorgestrel	6
A rare case of lupus cerebritis presenting as ictal epileptic headache: A case report	6
A qualitative evidence synthesis of patient perspectives on migraine treatment features and outcomes	6
Case report: Treatment of temporomandibular joint disorder pain with V3 nerve block procedure	6
Blood serum levels of PACAP and migraine onset: A systematic review and meta‐analysis of observational studies	6
Sex influences the progression of cephalic mechanical and light hypersensitivities in a mouse model of chronic migraine	6
Issue Information	6
Adverse childhood experiences and onset of migraine in Canadian adolescents: A cohort study	6
Changes in gamma‐aminobutyric acid and glutamate/glutamine levels in the right thalamus of patients with episodic and chronic migraine: A proton magnetic resonance spectroscopy study	6
Study participant impression of use and satisfaction with STS101 (dihydroergotamine nasal powder): Results from the open‐label ASCEND acute migraine study	6
Real world evidence of changes in CGRP monoclonal antibody and onabotulinumtoxinA prescription pra	6
Habitual caffeinated beverage consumption and headaches among adults with episodic migraine: A prospective cohort study	6
Altered brain functional connectivity in patients with tension‐type headache	6
Patient preferences for preventive migraine treatments among Canadian adults: A discrete choice experiment	6
Trainee highlights	6
Alterations in the structure and function of the brain in adolescents with new daily persistent headache: A pilot MRI study	6
Cost per treatment responder analysis of atogepant compared to rimegepant for the preventive treatment of episodic migraine	6
A multicenter, prospective, single‐arm study of 60‐day peripheral nerve stimulation of the occipital nerves for the treatment of headache	6
	6
	6
Are there differences between patients with unifocal nummular headache and those who progress to bifocal nummular headache? A retrospective observational study	6
Implementing screening and treatment for adverse childhood experiences in pediatric patients with headache at the Children's Hospital of Philadelphia	5
Cerebrospinal fluid and serum biomarkers in idiopathic intracranial hypertension: A systematic review	5
Biomarkers in cluster headache: A systematic review	5
	5
Exploring the relationship between pain catastrophizing and migraine in youth: A longitudinal clinical cohort study	5